[ET Net News Agency, 5 January 2023] ALPHAMAB-B (09966) rose 10% to HK$13.2.
It hits an intra-day high of HK$13.24, hitting an 1-month high, and an intra-day low of
HK$12.26. The total shares traded was 3.55 million, with a value of HK$45.65m. The active
buy/sell ratio is 63:37, with net buying turnover of HK$11.84m. CHINA INT'L CAPITAL CORP
HK accounts for greatest net responsive buying turnover of HK$991,671, with volume
weighted average price of HK$12.848. GOLDMAN SACHS (ASIA) SEC accounts for greatest net
responsive selling turnover of HK$510,658, with volume weighted average price of
HK$12.778. The stock has risen a combined 22.22% over the past 3 consecutive trading days.
Basic Information
=================
----------------------------------
Nominal 13.200 % Chg +10.00%
High 13.240 Low 12.260
Shares Tr 3.55m Turnover 45.65m
10-D SMA 10.815 %H.V 82.729
20-D SMA 10.424 VWAP 12.857
50-D SMA 8.819 RSI14 75.991
----------------------------------
Status: Hitting an 1-month high, active buy/sell ratio is 63:37, with net buying turnover
of HK$11.84m, rising a combined 22.22% over the past 3 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
ALPHAMAB-B (09966) 13.20 +10.00
ALI HEALTH (00241) 7.36 -0.54
INNOVENT BIO (01801) 35.70 +1.42
PA GOODDOCTOR (01833) 23.00 -3.16
JXR (01951) 7.16 -2.05
WUXI BIO (02269) 67.80 +2.42
HYGEIA HEALTH (06078) 59.20 +5.34
SCICLONE PHARMA (06600) 8.99 -1.53
JD HEALTH (06618) 73.15 -1.08
AKESO-B (09926) 46.30 -2.83
-----------------------------------------------
(ed)